Walmart will suspend the sale of Zantac and all forms of heartburn medicine containing the drug ranitidine after the Food and Drug Administration warned of potential cancer risk.
The world's largest employer said customers who purchased the products could return them to Walmart stores or Sam's Club locations for a refund.
|WMT||WALMART INC.|| 1
||-0.83  -0.70%|
Walmart joins other companies including Walgreens, Rite Aid and CVS Health to stop selling products containing ranitidine.
Zantac, the brand name version of the drug, is sold by Sanofi, but generic versions are distributed by other companies.
This is a news story, please check back for updates.